Acorda to buy Civitas Therapeutics for $525 million

September 24, 2014 1:01 PM

9 0

The deal effectively ends Civitas’s plans to go public

Acorda Therapeutics Inc. said Wednesday that it has agreed to buy fellow neurological drug maker Civitas Therapeutics for $525 million in cash, effectively putting an end to Civitas’s plans to go public.

Also read: California To Give Health Clinics $20 Million To Counter Possible Trump Cuts

Read more

To category page